Clinical Trials Logo

Intestinal Helminthiasis clinical trials

View clinical trials related to Intestinal Helminthiasis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03079700 Completed - Ulcerative Colitis Clinical Trials

Immune Modulation From Trichuris Suis

Start date: August 1, 2012
Phase: N/A
Study type: Observational

Mucosal immunology during helminth infection

NCT ID: NCT02399683 Completed - Crohn Disease Clinical Trials

Immune Modulation From Trichuris Trichiura

Start date: February 2012
Phase: N/A
Study type: Observational

Mucosal immunology during helminth infection

NCT ID: NCT01658774 Completed - Malaria Clinical Trials

Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children

Start date: January 2013
Phase: N/A
Study type: Interventional

Many school children in Kenya are infected with plasmodia and helminth species and are at risk of coinfection. It has been suggested that the immune response evoked by helminth infections may modify immune responses to plasmodia species and consequently alter infection and disease risks. However, studies conducted to date have been typically cross-sectional and produced conflicting results, and there is a need for longitudinal studies to better understand the clinical consequences for individuals harbouring coinfection. This study aims to investigate the impact of intensive (once every 3 months) anthelminthic treatment versus annual treatment on the risk of clinical malaria and on immune responses among school children aged 5-14 years in Western Province. Specifically, this study aims to investigate the impact of intensive anthelminthic treatment on (i) the incidence of clinical malaria in school children, assessed using active case detection; (ii) the prevalence and density of Plasmodium spp. infection, using repeat cross-sectional surveys; and (iii) malaria and helminth specific immune responses. The study hypothesis is that intensive anthelminthic treatment among children infected with either Ascaris lumbricoides or hookworm modifies human host immune responses to plasmodia and helminth infections, and therefore alters the risk of Plasmodium infection and clinical disease. This individually randomised trial will recruit 1,450 children aged 5-14 years found to be infected with either Ascaris lumbricoides or hookworm species. Recruited children will be randomized to receive albendazole treatment either every three months or annually and monitored through periodic surveillance for clinical malaria episodes over 18 months. In addition, blood samples will be collected from sub-sample of children and screened for malaria specific immunoglobulin (Ig)G1 and IgG3 and helminth specific IgE, IgG2, IgG4 and IgM. Cell culture supernatants will be assayed for interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-10, IL-5, IL-4 and IL-2.

NCT ID: NCT01640626 Completed - Clinical trials for Intestinal Helminthiasis

Impact of Health Education on School Children

Start date: July 2012
Phase: Phase 1
Study type: Interventional

There is a sever lack in application of health education intervention for Soil Transmitted Disease (STH) in rural communities and in school children among Orang Asli in Pahang in Malaysia, and also there is a lack of information on the effect of different health education aspects on STH control in Malaysia, so the investigators think that introducing such new national educational package and for the first time in Malaysian's school will help children to make some behavior changes specially for the school children aiming to use these children as an educator agents to their families and preschool brothers and sisters, to build a base for this issue and to reduce STH intensity in these rural areas, which in turn will determine the best approach to health education intervention to be applied to other rural areas in Malaysia.